BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

WuXi STA Launches Another Parenteral Formulation Manufacturing Line at Wuxi city site

This new line features a fully automatic vial loading/unloading system and a built-in 15 m2 lyophilizer in a fully enclosed isolator. The filling line...

December 01, 2022 | News

Digital Technologies Driving Transformational Growth Across the Biomanufacturing Value Chain

The biomanufacturing sector is experiencing a digitalization transformation that is aligned with Industry 4.0. According to Frost & Sullivan's recent a...

November 30, 2022 | News

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea

-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...

November 28, 2022 | News

WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility

WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmaceutical East China R&D facility in tandem with the signing ceremony...

November 24, 2022 | News

AcuCort signs its first commercial agreement for the company's drug Zeqmelit™

Kamada Ltd., a leading global biopharmaceutical company, has a well-established infrastructure for marketing, sales, and distribution of commercial pharmac...

November 24, 2022 | News

Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services

Snapdragon specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation techn...

November 22, 2022 | News

BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore

First mRNA manufacturing facility in Singapore will create regional manufacturing capacities in support of BioNTech’s growing pipeline of...

November 14, 2022 | News

Why Pharma and Medtech Should Digitize Quality in a Down Market

We tend to put off investments in improvements and instead opt to play it safe, taking a conservative approach to weathering the economic storm. For ...

November 01, 2022 | News | By Michelle Tanner, CFO, MasterControl

Merck Highlights New Data for Evobrutinib

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...

October 26, 2022 | News

Aragen to open a new formulation manufacturing facility

Facility will enhance Aragen’s offerings in clinical formulation development and manufacturing Will offer both integrated and stand-alone formulat...

October 21, 2022 | News

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned Partial operations add fresh biomanufacturing capacity of 60,000...

October 12, 2022 | News

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014

Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic dis...

October 10, 2022 | News

Cytiva strengthens cell line development with CEVEC acquisition

Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies 46 scientific experts based in Cologne, G...

October 06, 2022 | News

Univercells Technologies Completes EUR 2M Expansion of the Nivelles, Belgium Site

Nivelles site expansion activities began in December 2020 when the company doubled its overall footprint. The initial focus was on expanding warehouse stor...

October 06, 2022 | News

Stay Connected